Skip to main content
. 2021 Jul 30;13(15):3842. doi: 10.3390/cancers13153842

Table 4.

Hazard ratios and 95% confidence intervals of cancer incidence associated with mtDNA-CN (n = 2888) and relative telomere length (n = 3037).

Characteristics MtDNA-CN HR (95% CI)
per 1-SD Decrease in mtDNA-CN
Relative Telomere Length HR (95% CI)
per 1-SD Decrease in Telomere Length
p for Interaction c
High (n = 1406) Low (n = 1482) Long (n = 1473) Short (n = 1564)
All cancer
No. of cancer diagnoses 242 249 256 264
Person-years of follow-up 21,700 22,238 23,394 22,626
IR, per 1000 person-years 11.15 11.19 10.94 11.67
Crude HR (95% CI) 1 (Ref) 1.04 (0.87–1.24) 1.01 (0.92–1.10) 1 (Ref) 0.97 (0.82–1.16) 1.02 (0.94–1.11)
Adjusted HR (95% CI) a 1 (Ref) 0.99 (0.83–1.19) 0.99 (0.90–1.08) 1 (Ref) 0.93 (0.78–1.10) 1.00 (0.92–1.09) 0.607
Cancer types
(adjusted HR and 95% CI a)
Breast cancer 1 (Ref) 1.05 (0.78–1.42) 0.95 (0.84–1.08) 1 (Ref) 1.03 (0.77–1.38) 0.98 (0.84–1.14) 0.197
Digestive system 1 (Ref) 0.83 (0.54–1.29) 1.03 (0.84–1.26) 1 (Ref) 1.11 (0.71–1.72) 1.05 (0.88–1.25) 0.225
Respiratory system 1 (Ref) 0.91 (0.42–2.02) 1.18 (0.88–1.60) 1 (Ref) 0.58 (0.29–1.16) 0.83 (0.63–1.10) 0.192
Genital organs 1 (Ref) 0.60 (0.33–1.10) 0.84 (0.72–0.98) b 1 (Ref) 1.16 (0.66–2.05) 1.13 (0.87–1.47) 0.207
Urinary system 1 (Ref) 8.20 (1.06–63.2) b 1.08 (0.72–1.63) 1 (Ref) 1.35 (0.45–4.08) 1.79 (1.05–3.07) b <0.001
Hematological cancer 1 (Ref) 1.97 (1.02–3.81) b 1.11 (0.85–1.46) 1 (Ref) 0.81 (0.43–1.54) 0.97 (0.71–1.32) 0.007
Nervous system 1 (Ref) 1.62 (0.49–5.31) 1.07 (0.66–1.72) 1 (Ref) 0.68 (0.22–2.07) 0.74 (0.45–1.22) 0.314
Skin 1 (Ref) 0.82 (0.49–1.39) 1.05 (0.82–1.34) 1 (Ref) 0.81 (0.50–1.32) 1.11 (0.88–1.38) 0.171
Endocrine glands 1 (Ref) 0.79 (0.29–2.13) 1.01 (0.63–1.63) 1 (Ref) 0.67 (0.27–1.69) 0.76 (0.49–1.16) 0.331

a Adjusted for age, BMI, education level, smoking habits, alcohol consumption, activity at work, activity at home, diabetes, CVD, hypertension. b p < 0.05. c Interactions were calculated by inclusion of interaction terms. IR, incidence rate.